Abstract

For adequate and safe use of high-frequency jet ventilation (HFJV), reliable monitoring of the PCO2 status and course is necessary. Because of improved handling and performance, recently available transcutaneous PCO2 monitoring devices such as MicroGas 7650[trade mark sign] (Kontron Instruments Medical Sensors, Basel, Switzerland) should enable more effective surveillance of CO2 elimination and, subsequently, better control of subglottic HFJV. Adult patients (n = 164) undergoing laryngeal microsurgery during total IV anesthesia were assessed. The resulting transcutaneous PCO2 values, as well as the necessary driving pressure settings, were analyzed to define the CO2 elimination capacity of each patient. Therefore, an individual CO2 elimination coefficient (ECCO2) was calculated. The frequency distribution of the obtained ECCO2 values showed a normal distribution with a median at 0.79 and a range between 0.30 and 2.17. A significant difference in the frequency of obstructive lung disease was found between two patient subpopulations separated by the 25th percentile at an ECCO2 value of 0.63. Other co-factors of CO2 elimination during HFJV were age, gender, and body weight, whereas height and ventilation duration were not involved. We conclude that the individual assessment of ECCO2 enables one to find adequate ventilator settings, resulting in lower airway pressure and less cooling and drying of the tracheobronchial mucosa. Implications: CO2 elimination during high-frequency jet ventilation can be assessed by calculating the CO2 elimination coefficient (ECCO2) of each patient from the required driving pressure and the resulting transcutaneous CO2 partial pressure. The frequency distribution of ECCO2 in a typical laryngological patient population was analyzed, and a value of 0.63 was found to be a characteristic limit between sufficient and difficult CO (2) elimination. The individual assessment of ECCO2 enables one to find adequate ventilator settings, resulting in lower airway pressure and less cooling and drying of the tracheobronchial mucosa. (Anesth Analg 1998;87:180-4)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.